HIF-1-mediated metabolic reprogramming reduces ROS levels and facilitates the metastatic colonization of cancers in lungs

por Zhao, Tao, Zhu, Yuxi, Morinibu, Akiyo, Kobayashi, Minoru, Shinomiya, Kazumi, Itasaka, Satoshi, Yoshimura, Michio, Guo, Guozheng, Hiraoka, Masahiro, Harada, Hiroshi
Publicado 2014

Corrigendum: Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate toward tumour blood vessels

por Harada, Hiroshi, Inoue, Masahiro, Itasaka, Satoshi, Hirota, Kiichi, Morinibu, Akiyo, Shinomiya, Kazumi, Zeng, Lihua, Ou, Guangfei, Zhu, Yuxi, Yoshimura, Michio, Mckenna, W. Gillies, Muschel, Ruth J., Hiraoka, Masahiro
Publicado 2013

Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels

por Harada, Hiroshi, Inoue, Masahiro, Itasaka, Satoshi, Hirota, Kiichi, Morinibu, Akiyo, Shinomiya, Kazumi, Zeng, Lihua, Ou, Guangfei, Zhu, Yuxi, Yoshimura, Michio, McKenna, W. Gillies, Muschel, Ruth J., Hiraoka, Masahiro
Publicado 2012

LY6E: a conductor of malignant tumor growth through modulation of the PTEN/PI3K/Akt/HIF-1 axis

por Yeom, Chan Joo, Zeng, Lihua, Goto, Yoko, Morinibu, Akiyo, Zhu, Yuxi, Shinomiya, Kazumi, Kobayashi, Minoru, Itasaka, Satoshi, Yoshimura, Michio, Hur, Cheol-Goo, Kakeya, Hideaki, Hammond, Ester M., Hiraoka, Masahiro, Harada, Hiroshi
Publicado 2016

UCHL1 provides diagnostic and antimetastatic strategies due to its deubiquitinating effect on HIF-1α

por Goto, Yoko, Zeng, Lihua, Yeom, Chan Joo, Zhu, Yuxi, Morinibu, Akiyo, Shinomiya, Kazumi, Kobayashi, Minoru, Hirota, Kiichi, Itasaka, Satoshi, Yoshimura, Michio, Tanimoto, Keiji, Torii, Masae, Sowa, Terumasa, Menju, Toshi, Sonobe, Makoto, Kakeya, Hideaki, Toi, Masakazu, Date, Hiroshi, Hammond, Ester M., Hiraoka, Masahiro, Harada, Hiroshi
Publicado 2015